SensNews Sept 2020

Sensor100 September 2020 20 Rapid 90-minute COVID-19 test shown to be highly accurate The Lab-in-Cartridge rapid testing device, which can be performed at a patient’s bedside, was shown to have over 94% sensitivity and 100% specificity, which meant it had a high level of accuracy and produced very few false negatives and no false positives. The test is currently being used successfully across eight London hospitals, and due to be rolled out at a national level, and data con- tinues to be gathered from the testing device for continual assessment.The UK government recently placed an order for 5.8 million of the testing kits. A result is available within 90 minutes, com- pared to conventional COVID-19 testing which delivers a result in 24 hours. The test is now being developed for assessing simultane- ously Flu-A, Flu-B, and RSV as well as COVID19. The device, produced by DnaNudge, an Imperial start-up headquartered inWhite City, was used on 280 NHS staff members with suspected COVID-19, 15 patients in A&E with suspected COVID-19, and 91 hospital in-patients (some of who were not display- ing COVID-19 symptoms). Imperial College News 1 7 September Visby Medical’s Personal PCR Device Receives FDA Emergency Use Authorization Visby Medical’s test for COVID-19 is the first PCR-based, single-use test that is designed to be simple to operate; the palm-sized device is able to provide results in less than 30 minutes. Headquartered in San Jose, California, Visby Medical was founded in 2012 by Dr.Adam de la Zerda, CEO, with Gregory Loney, COO joining shortly thereafter as a founding executive. Visby Press Release 16 September The blue circular CovidNudge cartridge inside the NudgeBox analyser